PURPOSE: To study the importance of the @entity2840 ( @entity2840 ) in @entity1 with @entity2790 in a 2-year follow-up. METHODS: A total of 110 subjects with @entity2790 (intraocular pressure [IOP] >21 mmHg and normal automated visual field test) were admitted to the study. All @entity1 periodically underwent the following tests: 1) circadian IOP curve; 2) standard automated perimetry (SAP, Humphrey 30-2 SITA test); 3) short wavelength automated perimetry (SWAP); 4) frequency doubling technology perimetry (FDT, N-30 threshold test); 5) nerve fiber layer analysis with @entity9999 ; 6) @entity6309 test; 7) ultrasonic pachymetry. @entity1 were divided into three groups, based on corneal thickness. The frequency of abnormal tests within these groups was evaluated with the Pearson's chi2 test. Baseline IOP was corrected using the Doughty and Zaman formula. @entity2840 was also considered as a continuous variable. A control group of 48 normal subjects was also considered. RESULTS: The mean @entity2840 was 562.8 microm +/- 37.7. The difference with respect to normal subjects was statistically significant (p < 0.01). Using the correction formula, 43 eyes (39.1%) had an IOP <21 mmHg. Abnormal test results were more frequently found with FDT. The percentage of abnormal results was found to be inversely proportional to @entity2840 . The other tests gave inconsistent or conflicting results. Using the values of @entity2840 as a continuous variable, no significant association was found with the @entity9999 number and the visual field indices. CONCLUSIONS: The results of our 2-year study confirm the importance of @entity2840 measurement in the evaluation of the risk of developing @entity16 .

XXXX and corneal thickness: a long-term prospective study. Results after two years.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity2840 :: ('MESH:C563262', 'Disease') :: ['central corneal thickness', 'CCT'] @entity16 :: ('MESH:D009422', 'Disease') :: ['glaucomatous damage'] @entity9999 :: ('8266', 'Gene') :: ['GDx'] @entity2790 :: ('MESH:D009798', 'Disease') :: ['ocular hypertension'] @entity6309 :: ('MESH:C023487', 'Chemical') :: ['ibopamine']
@entity2790 :: (MESH:D009798,Disease) :: ['Ocular hypertension']
